Celularity Announces Over $10 Million Initial Financing Closing as Part of Up to $28 Million Recapitalization to Accelerate Growth Following Significant Operating Improvements
Globe Newswire•24/09/2026•09:15 ET
0
Plan combines up to $25 million in new capital with restructuring of $3 million in existing debt to support commercial execution and manufacturing expansion
Company anticipates positive monthly operating cash flow by the end of Q1 2027
Get started
Create a free account to read the full story and Whiz Insights.